User menu

The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.

Bibliographic reference Tosco, L ; Laenen, A ; Briganti, A ; Gontero, P ; Karnes, R J ; et. al. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.. In: Prostate Cancer and Prostatic Diseases, Vol. 20, p. 407-412 (2017)
Permanent URL http://hdl.handle.net/2078.1/189466
  1. Mottet Nicolas, Bellmunt Joaquim, Bolla Michel, Briers Erik, Cumberbatch Marcus G., De Santis Maria, Fossati Nicola, Gross Tobias, Henry Ann M., Joniau Steven, Lam Thomas B., Mason Malcolm D., Matveev Vsevolod B., Moldovan Paul C., van den Bergh Roderick C.N., Van den Broeck Thomas, van der Poel Henk G., van der Kwast Theo H., Rouvière Olivier, Schoots Ivo G., Wiegel Thomas, Cornford Philip, EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent, 10.1016/j.eururo.2016.08.003
  2. Mohler James L., Kantoff Philip W., Armstrong Andrew J., Bahnson Robert R., Cohen Michael, D’Amico Anthony Victor, Eastham James A., Enke Charles A., Farrington Thomas A., Higano Celestia S., Horwitz Eric Mark, Kane Christopher J., Kawachi Mark H., Kuettel Michael, Kuzel Timothy M., Lee Richard J., Malcolm Arnold W., Miller David, Plimack Elizabeth R., Pow-Sang Julio M., Raben David, Richey Sylvia, Roach Mack, Rohren Eric, Rosenfeld Stan, Schaeffer Edward, Small Eric J., Sonpavde Guru, Srinivas Sandy, Stein Cy, Strope Seth A., Tward Jonathan, Shead Dorothy A., Ho Maria, Prostate Cancer, Version 2.2014, 10.6004/jnccn.2014.0072
  3. Kumar S, Cochrane Database Syst Rev., 4, CD006019 (2006)
  4. Bartek J., Mistrik M., Bartkova J., Androgen Receptor Signaling Fuels DNA Repair and Radioresistance in Prostate Cancer, 10.1158/2159-8290.cd-13-0679
  5. Al-Ubaidi F. L. T., Schultz N., Loseva O., Egevad L., Granfors T., Helleday T., Castration Therapy Results in Decreased Ku70 Levels in Prostate Cancer, 10.1158/1078-0432.ccr-12-2795
  6. Joniau Steven, Van den Bergh Laura, Lerut Evelyne, Deroose Christophe M., Haustermans Karin, Oyen Raymond, Budiharto Tom, Ameye Filip, Bogaerts Kris, Van Poppel Hein, Mapping of Pelvic Lymph Node Metastases in Prostate Cancer, 10.1016/j.eururo.2012.06.057
  7. Fine Jason P., Gray Robert J., A Proportional Hazards Model for the Subdistribution of a Competing Risk, 10.2307/2670170
  8. Rosenbaum Paul R., Rubin Donald B., The Central Role of the Propensity Score in Observational Studies for Causal Effects, 10.2307/2335942
  9. Lin D. Y., Wei L. J., The Robust Inference for the Cox Proportional Hazards Model, 10.2307/2290085
  10. Abdollah Firas, Sun Maxine, Thuret Rodolphe, Jeldres Claudio, Tian Zhe, Briganti Alberto, Shariat Shahrokh F, Perrotte Paul, Montorsi Francesco, Karakiewicz Pierre I, Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer : Lymph node staging in prostate cancer, 10.1111/j.1442-2042.2012.02993.x
  11. Berglund Ryan K., Tangen Catherine M., Powell Isaac J., Lowe Bruce A., Haas Gabriel P., Carroll Peter R., Canby-Hagino Edith D., deVere White Ralph, Hemstreet George P., Crawford E. David, Thompson Ian M., Klein Eric A., Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109, 10.1016/j.urology.2011.11.019
  12. Moltzahn F, Karnes J, Gontero P, Kneitz B, Tombal B, Bader P, Briganti A, Montorsi F, Van Poppel H, Joniau S, Spahn M, Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients, 10.1038/pcan.2014.41
  13. Joniau Steven, Hsu Chao-Yu, Gontero Paolo, Spahn Martin, Van Poppel Hein, Radical prostatectomy in very high-risk localized prostate cancer: Long-term outcomes and outcome predictors, 10.3109/00365599.2011.637956
  14. Johnstone Peter A. S., Ward Kevin C., Goodman Michael, Assikis Vasily, Petros John A., Radical prostatectomy for clinical T4 prostate cancer, 10.1002/cncr.21926
  15. Culp Stephen H., Schellhammer Paul F., Williams Michael B., Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study, 10.1016/j.eururo.2013.11.012
  16. Taplin Mary-Ellen, Montgomery Bruce, Logothetis Christopher J., Bubley Glenn J., Richie Jerome P., Dalkin Bruce L., Sanda Martin G., Davis John W., Loda Massimo, True Lawrence D., Troncoso Patricia, Ye Huihui, Lis Rosina T., Marck Brett T., Matsumoto Alvin M., Balk Steven P., Mostaghel Elahe A., Penning Trevor M., Nelson Peter S., Xie Wanling, Jiang Zhenyang, Haqq Christopher M., Tamae Daniel, Tran NamPhuong, Peng Weimin, Kheoh Thian, Molina Arturo, Kantoff Philip W., Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study, 10.1200/jco.2013.53.4578
  17. Efstathiou Jason A., Heunis Magda, Karumekayi Talkmore, Makufa Remigio, Bvochora-Nsingo Memory, Gierga David P., Suneja Gita, Grover Surbhi, Kasese Joseph, Mmalane Mompati, Moffat Howard, von Paleske Alexander, Makhema Joseph, Dryden-Peterson Scott, Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of Botswana, 10.1200/jco.2015.62.8412
  18. Jorgensen Timothy J., Enhancing radiosensitivity: Targeting the DNA repair pathways, 10.4161/cbt.8.8.8304
  19. Polkinghorn W. R., Parker J. S., Lee M. X., Kass E. M., Spratt D. E., Iaquinta P. J., Arora V. K., Yen W.-F., Cai L., Zheng D., Carver B. S., Chen Y., Watson P. A., Shah N. P., Fujisawa S., Goglia A. G., Gopalan A., Hieronymus H., Wongvipat J., Scardino P. T., Zelefsky M. J., Jasin M., Chaudhuri J., Powell S. N., Sawyers C. L., Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers, 10.1158/2159-8290.cd-13-0172
  20. Goodwin J. F., Schiewer M. J., Dean J. L., Schrecengost R. S., de Leeuw R., Han S., Ma T., Den R. B., Dicker A. P., Feng F. Y., Knudsen K. E., A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult, 10.1158/2159-8290.cd-13-0108
  21. Tarish F. L., Schultz N., Tanoglidi A., Hamberg H., Letocha H., Karaszi K., Hamdy F. C., Granfors T., Helleday T., Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair, 10.1126/scitranslmed.aac5671
  22. Jackson William C., Schipper Matthew J., Johnson Skyler B., Foster Corey, Li Darren, Sandler Howard M., Palapattu Ganesh S., Hamstra Daniel A., Feng Felix Y., Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy, 10.1016/j.eururo.2015.05.009